Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda.
Saved in:
| Title: | Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda. |
|---|---|
| Authors: | Abaasa AM; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK. Electronic address: andrew.abaasa@lshtm.ac.uk., Kusemererwa S; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda., Ankunda V; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda., Ongaria TA; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda., Nayiga B; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda., Kakande A; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda., Ssemwanga D; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK., Kimbugwe G; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda., Bosa HK; Ministry of Health, Kampala, Uganda., Woldemariam YT; World Health Organisation Country Office, Kampala, Uganda., Kisakye A; World Health Organisation Country Office, Kampala, Uganda., Humphreys J; Epiconcept company, Paris, 75011, France., Worwui AK; The African Region Monitoring Vaccine Effectiveness (AFRO-MoVE) Network, World Health Organisation - Regional Office for Africa, Brazzaville, the Democratic Republic of the Congo., Cohuet S; The African Region Monitoring Vaccine Effectiveness (AFRO-MoVE) Network, World Health Organisation - Regional Office for Africa, Brazzaville, the Democratic Republic of the Congo., Mwenda JM; The African Region Monitoring Vaccine Effectiveness (AFRO-MoVE) Network, World Health Organisation - Regional Office for Africa, Brazzaville, the Democratic Republic of the Congo., Elliott AM; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK., Kaleebu P; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK., Ruzagira E; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK. |
| Source: | Vaccine [Vaccine] 2026 Apr 02; Vol. 77 Suppl 1, pp. 126976. Date of Electronic Publication: 2025 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40055029 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Abaasa+AM%22">Abaasa AM</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK. Electronic address: andrew.abaasa@lshtm.ac.uk.<br /><searchLink fieldCode="AU" term="%22Kusemererwa+S%22">Kusemererwa S</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Ankunda+V%22">Ankunda V</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Ongaria+TA%22">Ongaria TA</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Nayiga+B%22">Nayiga B</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Kakande+A%22">Kakande A</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Ssemwanga+D%22">Ssemwanga D</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Kimbugwe+G%22">Kimbugwe G</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Bosa+HK%22">Bosa HK</searchLink>; Ministry of Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Woldemariam+YT%22">Woldemariam YT</searchLink>; World Health Organisation Country Office, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Kisakye+A%22">Kisakye A</searchLink>; World Health Organisation Country Office, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Humphreys+J%22">Humphreys J</searchLink>; Epiconcept company, Paris, 75011, France.<br /><searchLink fieldCode="AU" term="%22Worwui+AK%22">Worwui AK</searchLink>; The African Region Monitoring Vaccine Effectiveness (AFRO-MoVE) Network, World Health Organisation - Regional Office for Africa, Brazzaville, the Democratic Republic of the Congo.<br /><searchLink fieldCode="AU" term="%22Cohuet+S%22">Cohuet S</searchLink>; The African Region Monitoring Vaccine Effectiveness (AFRO-MoVE) Network, World Health Organisation - Regional Office for Africa, Brazzaville, the Democratic Republic of the Congo.<br /><searchLink fieldCode="AU" term="%22Mwenda+JM%22">Mwenda JM</searchLink>; The African Region Monitoring Vaccine Effectiveness (AFRO-MoVE) Network, World Health Organisation - Regional Office for Africa, Brazzaville, the Democratic Republic of the Congo.<br /><searchLink fieldCode="AU" term="%22Elliott+AM%22">Elliott AM</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Kaleebu+P%22">Kaleebu P</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Ruzagira+E%22">Ruzagira E</searchLink>; MRC/UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2026 Apr 02; Vol. 77 Suppl 1, pp. 126976. <i>Date of Electronic Publication: </i>2025 Mar 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40055029 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2025.126976 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 126976 Titles: – TitleFull: Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Abaasa AM – PersonEntity: Name: NameFull: Kusemererwa S – PersonEntity: Name: NameFull: Ankunda V – PersonEntity: Name: NameFull: Ongaria TA – PersonEntity: Name: NameFull: Nayiga B – PersonEntity: Name: NameFull: Kakande A – PersonEntity: Name: NameFull: Ssemwanga D – PersonEntity: Name: NameFull: Kimbugwe G – PersonEntity: Name: NameFull: Bosa HK – PersonEntity: Name: NameFull: Woldemariam YT – PersonEntity: Name: NameFull: Kisakye A – PersonEntity: Name: NameFull: Humphreys J – PersonEntity: Name: NameFull: Worwui AK – PersonEntity: Name: NameFull: Cohuet S – PersonEntity: Name: NameFull: Mwenda JM – PersonEntity: Name: NameFull: Elliott AM – PersonEntity: Name: NameFull: Kaleebu P – PersonEntity: Name: NameFull: Ruzagira E IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 04 Text: 2026 Apr 02 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 77 Suppl 1 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |